498 related articles for article (PubMed ID: 3342414)
21. The measurement of urinary beta core fragment in conjunction with serum CA125 does not aid the differentiation of malignant from benign pelvic masses.
Carter PG; Iles RK; Neven P; Davies AP; Shepherd JH; Chard T
Gynecol Oncol; 1993 Dec; 51(3):368-71. PubMed ID: 8112647
[TBL] [Abstract][Full Text] [Related]
22. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease.
Alfthan H; Haglund C; Roberts P; Stenman UH
Cancer Res; 1992 Sep; 52(17):4628-33. PubMed ID: 1324787
[TBL] [Abstract][Full Text] [Related]
23. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies.
Wang YX; Schwartz PE; Chambers JT; Cole LA
Gynecol Oncol; 1988 Sep; 31(1):91-102. PubMed ID: 3410359
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors.
Hoermann R; Gerbes AL; Spoettl G; Jüngst D; Mann K
Cancer Res; 1992 Mar; 52(6):1520-4. PubMed ID: 1540961
[TBL] [Abstract][Full Text] [Related]
25. Urine hCG beta-subunit core fragment, a sensitive test for ectopic pregnancy.
Cole LA; Kardana A; Seifer DB; Bohler HC
J Clin Endocrinol Metab; 1994 Feb; 78(2):497-9. PubMed ID: 7508952
[TBL] [Abstract][Full Text] [Related]
26. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
[TBL] [Abstract][Full Text] [Related]
27. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
[TBL] [Abstract][Full Text] [Related]
28. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
[TBL] [Abstract][Full Text] [Related]
29. Cross-reactivity of a commercial chemiluminescence immunoassay for human chorionic gonadotropin with the free beta-subunit.
Luppa P; Spöttl G; Saller B; Neumeier D; Mann K
J Biolumin Chemilumin; 1992 Jul; 7(3):195-201. PubMed ID: 1381136
[TBL] [Abstract][Full Text] [Related]
30. Carboxyterminal peptide fragments of the beta subunit are urinary products of the metabolism of desialylated human choriogonadotropin.
Amr S; Rosa C; Birken S; Canfield R; Nisula B
J Clin Invest; 1985 Jul; 76(1):350-6. PubMed ID: 4019785
[TBL] [Abstract][Full Text] [Related]
31. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
32. Stability of immunoreactive beta-core fragment of hCG.
de Medeiros SF; Amato F; Norman RJ
Obstet Gynecol; 1991 Jan; 77(1):53-9. PubMed ID: 1984227
[TBL] [Abstract][Full Text] [Related]
33. Urinary concentrations of beta core fragment of hCG throughout pregnancy.
de Medeiros SF; Amato F; Matthews CD; Norman RJ
Obstet Gynecol; 1992 Aug; 80(2):223-8. PubMed ID: 1378955
[TBL] [Abstract][Full Text] [Related]
34. Enzyme Immunoassay of Urinary β-Core Fragment of Human Chorionic Gonadotropin as a Tumor Marker for Ovarian Cancer.
Nishimura R; Koizumi T; Das H; Takemori M; Hasegawa K
Methods Mol Med; 2001; 39():135-41. PubMed ID: 21340764
[TBL] [Abstract][Full Text] [Related]
35. Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma.
Ordóñez NG; Ayala AG; Raymond AK; Plager C; Benjamin RS; Samaan NA
Arch Pathol Lab Med; 1989 Apr; 113(4):416-9. PubMed ID: 2468324
[TBL] [Abstract][Full Text] [Related]
36. Specificity and detection limit of ten pregnancy tests.
Alfthan H; Björses UM; Tiitinen A; Stenman UH
Scand J Clin Lab Invest Suppl; 1993; 216():105-13. PubMed ID: 7690982
[TBL] [Abstract][Full Text] [Related]
37. UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGP.
Schwarz-Roeger U; Petzoldt B; Waldschmidt R; Walker RP; Bauknecht T; Kiechle M
Anticancer Res; 1997; 17(4B):3041-5. PubMed ID: 9329597
[TBL] [Abstract][Full Text] [Related]
38. The quagmire of hCG and hCG testing in gynecologic oncology.
Muller CY; Cole LA
Gynecol Oncol; 2009 Mar; 112(3):663-72. PubMed ID: 19007977
[TBL] [Abstract][Full Text] [Related]
39. Beta-core fragment of human chorionic gonadotropin in cervical intraepithelial neoplasia (CIN).
Norman RJ; de Medeiros S; Amato F; Davis G; Davy M
Gynecol Oncol; 1993 Apr; 49(1):16-8. PubMed ID: 8482553
[TBL] [Abstract][Full Text] [Related]
40. Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.
Cole LA; Nam JH
Yale J Biol Med; 1989; 62(4):367-78. PubMed ID: 2596125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
